- Editas Medicine ( NASDAQ: EDIT ) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, before market open.
- The consensus EPS Estimate is -$0.81 (-32.8% Y/Y) and the consensus Revenue Estimate is $3.76M (-69.8% Y/Y).
- Over the last 1 year, EDIT has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 1 downward. Revenue estimates have seen 1 upward revision and 2 downward.
For further details see:
Editas Medicine Q4 2022 Earnings Preview